Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

How we stumbled on the role of the vagus nerve in chronic inflammation

Link to the podcast Metagenics Institute Podcast: The Power and the Potential of the Vagus Nerve to Combat Inflammation with Prof Paul Peter Tak ( Introduction Welcome to “The P…

Pioneering Gut Science, Kintai Therapeutics Is Bringing a New Small Molecule Modality to Fruition

What if the gut, widely regarded as the body’s second brain, could offer a much more impactful means to effect broad systemic pharmacological actions of orally administered drugs based on the conflu…

Targeting Immuno-Inflammation: Where Industry and Academia Interface

Although inflammation is a necessary biological process in response to injury and disease, at abnormal levels it is also responsible for a significant annual health burden. Immune-mediated inflammat…

Innovation in Development the Disruptive Advantages of Experimental Medicine

Paul-Peter Tak, co-founder of a cancer tech startup, provides an Expert View about innovation in development and the advantages of experimental medicine. Just over 140 years ago, the world’s firs…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.